Iprazest Respules are used to manage bronchospasm associated with chronic obstructive pulmonary disease (COPD) in adults, including chronic bronchitis and emphysema, improving breathing by relaxing and widening the airways.
They combine ipratropium (0.5 mg) and levosalbutamol (1.25 mg), a dual bronchodilator for use via nebuliser. Use them as prescribed; rinse your mouth after use to reduce throat irritation.
Quitting smoking, avoiding known triggers and keeping to all monitoring appointments support better respiratory health alongside this medicine.
Tell your doctor about any glaucoma, prostate problems or heart conditions before starting. Report significant palpitations, worsening breathlessness or eye pain immediately.
_iprazest-125-mg500mcg-respules-25-ml-pack-of-5--TM-RESE1-000126_1.png?width=320)











































